 Marinus Pharmaceuticals Inc NASDAQ:MRNS Stock analysts at Oppenheimer raised their Q3 2020 earnings per share EPS estimates for Marinus Pharmaceuticals in a report issued on Tuesday, June 30th. Oppenheimer analyst J. Olson now anticipates that the biopharmaceutical company will post earnings of 0.17 per share for the quarter, up from their prior forecast of ... 